Materials & Resources » Chemicals | Phibro Animal Health Corp.

Phibro Animal Health Corp. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,127.00
60,280.00
82,728.00
64,615.00
64,883.00
Depreciation, Depletion & Amortization
21,453.00
21,373.00
23,218.00
25,866.00
26,895.00
Other Funds
7,905.00
757.00
426.00
7,429.00
5,719.00
Funds from Operations
27,520.00
85,657.00
83,276.00
97,882.00
103,886.00
Changes in Working Capital
28,232.00
16,953.00
46,058.00
503.00
33,878.00
Net Operating Cash Flow
712.00
68,704.00
37,218.00
98,385.00
70,008.00
Capital Expenditures
19,846.00
20,058.00
36,352.00
20,880.00
18,548.00
Purchase/Sale of Investments
-
-
-
-
50,000.00
Net Investing Cash Flow
19,412.00
34,464.00
82,791.00
21,942.00
84,612.00
Cash Dividends Paid - Total
25,000.00
15,595.00
15,708.00
15,827.00
16,073.00
Issuance/Reduction of Debt, Net
84,650.00
1,090.00
62,071.00
43,452.00
1,401.00
Net Financing Cash Flow
4,779.00
15,351.00
50,380.00
53,738.00
11,775.00
Net Change in Cash
15,548.00
17,395.00
4,389.00
22,478.00
26,915.00
Free Cash Flow
20,558.00
48,646.00
866.00
77,505.00
51,460.00
Deferred Taxes & Investment Tax Credit
1,289.00
4,761.00
22,244.00
28.00
6,389.00
Net Assets from Acquisitions
-
10,377.00
46,576.00
-
15,000.00
Other Sources
434.00
-
137.00
-
-
Change in Capital Stock
114,429.00
1,334.00
4,017.00
5,541.00
5,699.00
Exchange Rate Effect
203.00
1,494.00
418.00
227.00
536.00
Other Uses
-
4,029.00
-
1,062.00
1,064.00

About Phibro Animal Health

View Profile
Address
Glenpointe Centre East
Teaneck New Jersey 07666
United States
Employees -
Website http://www.pahc.com
Updated 07/08/2019
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.